Global Tyrosine Protein Kinase Mer Pipeline Overview 2020 with Analysis by Indication, Stage of Development, Mechanism of Action, Route of Administration and Molecule Type
Retrieved on:
Thursday, March 26, 2020
DUBLIN, March 26, 2020 /PRNewswire/ -- The "Tyrosine Protein Kinase Mer - Pipeline Review, H1 2020" drug pipelines has been added to ResearchAndMarkets.com's offering.
Key Points:
- DUBLIN, March 26, 2020 /PRNewswire/ -- The "Tyrosine Protein Kinase Mer - Pipeline Review, H1 2020" drug pipelines has been added to ResearchAndMarkets.com's offering.
- Tyrosine Protein Kinase Mer (Proto Oncogene c Mer or Receptor Tyrosine Kinase MerTK or MERTK or EC 2.7.10.1) pipeline Target constitutes close to 19 molecules.
- This report outlays comprehensive information on the Tyrosine Protein Kinase Mer targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type.
- It also reviews key players involved in Tyrosine Protein Kinase Mer targeted therapeutics development with respective active and dormant or discontinued projects.